Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

July 23, 2007

Primary Completion Date

September 14, 2009

Study Completion Date

September 14, 2009

Conditions
Cytomegalovirus Infections
Interventions
DRUG

maribavir

100mg twice a day for 14 weeks.

DRUG

ganciclovir

1000mg three times per day for 14 weeks.

Trial Locations (55)

10016

NYU School of Medicine, New York

10032

Columbia University Medical Center, New York

10595

New York Medical College, Valhalla

14642

University of Rochester Medical Center- Strong Memorial, Rochester

15240

VA Pittsburgh Healthcare System, Pittsburgh

19104

University of Pennsylvania Hospital, Philadelphia

20007

Georgetown University, Washington D.C.

22908

University of Virginia Health System, Charlottesville

23298

Virginia Commonwealth University, Richmond

27599

University of North Carolina, Chapel Hill, Chapel Hill

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

30322

Emory University, Atlanta

32224

Mayo Clinic College of Medicine, Jacksonville

33606

Tampa General, Tampa

38104

Methodist Transplant Institute, Memphis

40202

Jewish Hospital Louisville, Louisville

40536

University of Kentucky Chandler Medical Center, Lexington

44195

Cleveland Clinic Foundation, Cleveland

45267

University of Cincinnati Medical Center, Cincinnati

48109

University of Michigan, Ann Arbor

48202

Henry Ford Health System, Detroit

52242

University of Iowa Hospitals and Clinics, Iowa City

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic Rochester, Rochester

60611

Northwestern University Medical Center, Chicago

60612

Rush University Medical Center, Chicago

University of Illinois at Chicago, Chicago

60637

University of Chicago Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Medical Center, Kansas City

68198

University of Nebraska, Omaha

70112

Tulane University Hospital and Clinic, New Orleans

70121

Ochsner Clinic, New Orleans

73112

Integris Baptist Medical Center, Oklahoma City

75246

Baylor University Medical Center (Dallas), Dallas

77030

Baylor College of Medicine (Houston), Houston

Methodist Hospital, Houston

UT Memorial Hermann Hospital and Texas Liver Center, Houston

78229

University of Texas Health Sciences Center at San Antonio, San Antonio

80045

University of Colorado Health Sciences Center, Aurora

85006

Mayo Clinic Arizona, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

90095

UCLA Medical Center, Los Angeles

92103

University of California at San Diego, La Jolla

94143

University of California at San Francisco, San Francisco

94305

Stanford University Medical Center, Stanford

97239

Oregon Health and Sciences University, Portland

02111

New England Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01805

Lahey Clinic, Burlington

07101

University of Medicine and Dentistry of New Jersey, Newark

98195-7110

Univeristy of Washington Medical Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shire

INDUSTRY

NCT00497796 - Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients | Biotech Hunter | Biotech Hunter